General practitioners' views on polypharmacy and its consequences for patient health care

BMC Family Practice

Volumn 14, Issue , 2013, Pages

  Köberlein, Juliane ^a   Gottschall, Mandy ^a,b   Czarnecki, Kathrin ^a   Thomas, Alexander ^b   Bergmann, Antje ^b   Voigt, Karen ^b  

^a UNIVERSITY OF WUPPERTAL   (Germany)

^b UNIVERSITY OF DRESDEN MEDICAL SCHOOL   (Germany)

Author keywords

General practitioner; Health services research; Multimorbidity; Polypharmacy

Indexed keywords

ADVERSE DRUG REACTION; AGED; ARTICLE; CHRONIC DISEASE; CLINICAL PRACTICE; COMORBIDITY; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; ELDERLY CARE; FEMALE; GENERAL PRACTITIONER; GERMANY; HEALTH SERVICE; HUMAN; INAPPROPRIATE PRESCRIBING; MALE; ORGANIZATION AND MANAGEMENT; POLYPHARMACY; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; RETROSPECTIVE STUDY; SOCIOECONOMICS; STANDARD; TREATMENT OUTCOME; URBAN POPULATION; PREVENTION AND CONTROL; PSYCHOLOGY; STANDARDS;

AGED; CHRONIC DISEASE; COMORBIDITY; CROSS-SECTIONAL STUDIES; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; GENERAL PRACTITIONERS; GERMANY; HEALTH SERVICES FOR THE AGED; HEALTH SERVICES MISUSE; HUMANS; INAPPROPRIATE PRESCRIBING; MALE; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PHYSICIAN'S PRACTICE PATTERNS; POLYPHARMACY; QUESTIONNAIRES; RETROSPECTIVE STUDIES; SOCIOECONOMIC FACTORS; URBAN POPULATION; PRACTICE PATTERNS, PHYSICIANS'; SURVEYS AND QUESTIONNAIRES;

EID: 84881460557     PISSN: None     EISSN: 14712296     Source Type: Journal    
DOI: 10.1186/1471-2296-14-119     Document Type: Article

References (57)

1. Comorbidity or multimorbidity: what's in a name. A review of literature. van den Akker M, Buntinx F, Knottnerus J, Eur J Gen Pract 1996 2 65 70 10.3109/13814789609162146
2. Herausforderungen an die Gesundheitsforschung für eine alternde Gesellschaft am Beispiel "Multimorbidität" Scheidt-Nave C, Richter S, Fuchs J, Kuhlmey A, Bundesgesundheitsbl 2010 53 441 450 10.1007/s00103-010-1052-9
3. Kosten der intensivmedizinischen Versorgung in einem deutschen Krankenhaus. Martin J, Neurohr C, Bauer M, Weiß M, Schleppers A, Anaesthesist 2008 5 505 512
4. Abdulla W, Interdisziplinäre Intensivmedizin Muenchen: Elsevier GmbH 2007 19851957
5. Analysis of the North Carolina long-term care polypharmacy initiative: a multiple-cohort approach using propensity-score matching for both evaluation and targeting. Trygstad TK, Christensen DB, Wegner SE, Sullivan R, Garmise JM, Clin Ther 2009 31 2018 2037 10.1016/j.clinthera.2009.09.006 19843492
6. A medication therapy management program's impact on low-density lipoprotein cholesterol goal attainment in Medicare Part D patients with diabetes. Fox D, Ried LD, Klein GE, Myers W, Foli K, J Am Pharm Assoc 2009 49 192 199 10.1331/JAPhA.2009.09016
7. Clinical and economic outcomes of medication therapy management services: the Minnesota experience. Isetts BJ, Schondelmeyer SW, Artz MB, Lenarz LA, Heaton AH, Wadd WB, Brown LM, Cipolle RJ, J Am Pharm Assoc (2003) 2008 48 203 211 203 p following 211 10.1331/JAPhA.2008.07108
8. Analysis of pharmacist-provided medication therapy management (MTM) services in community pharmacies over 7 years. Barnett MJ, Frank J, Wehring H, Newland B, VonMuenster S, Kumbera P, Halterman T, Perry PJ, J Manag Care Pharm 2009 15 18 31 19125557
9. Aging in the eighties: the prevalence of comorbidity and its association with disability. Guralnick J, Aging in the eighties: the prevalence of comorbidity and its association with disability, vol. 170 Hyattsville: DHHS publication 1989 89 1250
10. Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Wolff JL, Starfield B, Anderson G, Arch Intern Med 2002 162 2269 2276 10.1001/archinte.162.20.2269 12418941
11. Persons with chronic conditions. Their prevalence and costs. Hoffman C, Rice D, Sung HY, JAMA 1996 276 1473 1479 10.1001/jama.1996.03540180029029 8903258
12. Multimorbidity in general practice: prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases. van den Akker M, Buntinx F, Metsemakers JF, Roos S, Knottnerus JA, J Clin Epidemiol 1998 51 367 375 10.1016/S0895-4356(97)00306-5 9619963
13. Computerized health information in The Netherlands: a registration network of family practices. Metsemakers JF, Hoppener P, Knottnerus JA, Kocken RJ, Limonard CB, Br J Gen Pract 1992 42 102 106 1493025
14. Morbidity, comorbidity, and their association with disability among community-dwelling oldest-old in Israel. Fuchs Z, Blumstein T, Novikov I, Walter-Ginzburg A, Lyanders M, Gindin J, Habot B, Modan B, J Gerontol A Biol Sci Med Sci 1998 53 447 455 9823749
15. Enquête Sociale et de Santé 1998. Daveluy C, Pica L, Audet N, Courtemanche R, Lapointe F, Enquête Sociale et de Santé 1998, vol. 2 Québec: Institut de la statistique du Québec 2001 17703338
16. Prevalence of multimorbidity among adults seen in family practice. Fortin M, Bravo G, Hudon C, Vanasse A, Lapointe L, Ann Fam Med 2005 3 223 228 10.1370/afm.272 15928225
17. Kohler M, Ziese T, Telefonischer Gesundheitssurvey des Robert Koch-Instituts zu chronischen Krankheiten und ihren Bedingungen Robert-Koch-Institut: In Telefonischer Gesundheitssurvey des Robert Koch-Instituts zu chronischen Krankheiten und ihren Bedingungen 2004
18. Zur Inzidenz und Prävalenz von Mehrfachkrankheiten in Deutschland. Wiesner G, Bittner E, ArbeitsmedSozialmedUmweltmed 2005 40 490 498
19. Lindenberger U, Smith J, Mayer K, Baltes P, Die Berliner Altersstudie Berlin: Akademie Verlag 2010
20. Which chronic diseases and disease combinations are specific to multimorbidity in the elderly? Results of a claims data based cross-sectional study in Germany. van den Bussche H, Koller D, Kolonko T, Hansen H, Wegscheider K, Glaeske G, von Leitner EC, Schafer I, Schon G, BMC Publ Health 2011 11 101 10.1186/1471-2458-11-101
21. Häufige Beratungsanlässe mit Multimorbidität-Ergebnisse der 4. Sächsischen Epidemiologischen Studie der Allgemeinmedizin (SESAM-4) der Sächsischen Gesellschaft fur Allgemeinmedizin (SGAM). Thomas A, Voigt K, Riemenschneider H, Voigt R, Bergmann A, Z Allg Med 2012 88 102
22. Co- and multimorbidity patterns in primary care based on episodes of care: results from the German CONTENT project. Laux G, Kuehlein T, Rosemann T, Szecsenyi J, BMC Health Serv Res 2008 8 14 10.1186/1472-6963-8-14 18205916
23. Potentially inappropriate medications in the elderly: the PRISCUS list. Holt S, Schmiedl S, Thurmann PA, Dtsch Arztebl Int 2010 107 543 551 20827352
24. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA, JAMA 2002 287 337 344 10.1001/jama.287.3.337 11790213
25. Potentially inappropriate medication use among elderly home care patients in Europe. Fialova D, Topinkova E, Gambassi G, Finne-Soveri H, Jonsson PV, Carpenter I, Schroll M, Onder G, Sorbye LW, Wagner C, et al. JAMA 2005 293 1348 1358 10.1001/jama.293.11.1348 15769968
26. Körperliche Aktivität, Multimorbidität und Multimedikation im hohen Lebensalter: Analysen in der getABI-Kohorte http://dbf.zqp.de/display. php?pid?=?351 23961406
27. Polypharmazie bei älteren Patienten in Sachsen. Maywald U, Hach I, Aerzteblatt Sachsen 2005 10 459
28. Boehm K, Tesch-Roemer C, Ziese T, Gesundheit und Krankheit im Alter Robert-Koch-Institut: In Gesundheit und Krankheit im Alter 2009
29. Potential side-effects and interactions in multiple medication in elderly patients: methodology and results of the Berlin Study of Aging. Borchelt M, Z Gerontol Geriatr 1995 28 420 428 8581761
30. Drug effects in elderly subjects: from the pharmacologic target to the risk-benefit. Round Table #5 of the 16th National Clinical Pharmacology Workshop. Lassale C, Piette F, Jolliet P, Therapie 2001 56 363 367 11677853
31. Probleme bei der Pharmakotherapie älterer Patienten. Burkhardt H, Wehling M, Internist 2010 51 737 746 10.1007/s00108-010-2582-9 20424813
32. Morbidität, Medikation und Funktionalität im Alter. Steinhagen-Thiessen E, Borchelt M, Die Berliner Altersstudie Berlin: Akademie Verlag, Mayer K, Baltes P, 1996 151 183
33. Glaeske G, Jahnsen K, GEK-Arzneimittel-Report 2006 St. Augustin: Asgard-Verlag 2006
34. Mulimedikation, Compliance und Zusatzmedikation bei Patienten mit kardiovaskulären Erkrankungen. Rottlaender D, Scherner M, Schneider T, Erdmann E, DMW 2007 132 139 144 10.1055/s-2007-959300
35. Sachverstaendigenrat zur Begutachtung der Entwicklung im Gesundheitswesen, Kooperation und Verantwortung. Voraussetzung einer zielorientierten Gesundheitsversorgung Bonn: Kooperation und Verantwortung. Voraussetzung einer zielorientierten Gesundheitsversorgung Gutachten. 2007
36. Health care use and costs of adverse drug events emerging from outpatient treatment in Germany: a modelling approach. Stark RG, John J, Leidl R, BMC Health Serv Res 2011 11 9 10.1186/1472-6963-11-9 21232111
37. Prävention unerwünschter Arzneimittelwirkungen bei älteren Patienten. Burkhardt H, Wehling M, Gladisch R, Z Gerontol Geriat 2007 40 241 254 10.1007/s00391-007-0468-9
38. Arzneimittelanwendung im Alter. Jaehde U, Lengeling S, Liekweg A, Angewandte Arzneimitteltherapie Heidelberg: Springer-Verlag, Schneemann H, Young LY, Koda-Kimble MA, 2001 757 770
39. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Mangoni AA, Jackson SH, Br J Clin Pharmacol 2004 57 6 14 14678335
40. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH, Arch Intern Med 2003 163 2716 2724 10.1001/archinte.163.22.2716 14662625
41. Potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients. Hamilton H, Gallagher P, Ryan C, Byrne S, O'Mahony D, Arch Intern Med 2011 171 1013 1019 10.1001/archinternmed.2011.215 21670370
42. Reisig M, Implementierung und Evaluation eines computergestützten Systems zur Optimierung der individuellen Arzneimitteltherapie Department of natural sciences: University of Erlangen-Nuernberg 2006
43. Home Medication Review-a structured and collaborative service for multimorbid type 2 diabetic patients provided by community pharmacies and practitioners. Krueger M, Griese N, 17. Jahrestagung der Gesellschaft für Arzneimittelanwendungsforschung und Arzneimittelepidemiologie; Osnabrueck Duesseldorf: German Medical Science GMS Publishing House 2010
44. Potentials to optimize the pharmacotherapy of geriatric residents in nursing homes by pharmaceutical care. Kruse J, Waltering I, Puteanus U, Hempel G, 16. Jahrestagung der Gesellschaft für Arzneimittelanwendungsforschung und Arzneimittelepidemiologie; Düsseldorf Duesseldorf: German Medical Science GMS Publishing House 2009
45. Bundesamt S, German population by age-groups and federal states Statistisches Bundesamt: In German population by age-groups and federal states 2012
46. Regionale Unterschiede in Arzneimittelverbrauch und -kosten. Häussler B, Hempel E, Albrecht M, Klein S, Gesundheits- und Sozialpolitik 2007 61 12 17
47. Regionale Unterschiede in der Nutzung des Aut-idem-Verbots bei Älteren nach Einführung der Rabattverträge. Hoffmann F, Windt R, Glaeske G, Gesundheitswesen 2011 73 438 442 10.1055/s-0030-1253442 20544592
48. TNF-alpha Blocker: Versorgungssituation und regionale Unterschiede. Windt R, Deutscher Kongress für Versorgungsforschung Koeln: DNVF 2011
49. Deutscher Bundestag, Gesetz zur Verbesserung der Versorgungsstrukturen in der gesetzlichen Krankenversicherung (GKV-Versorgungsstrukturgesetz GKV-VStG) Bonn: Bundesgesetzblatt 2011, Teil 1 Nr. 70 2011
50. Keeping the Wire Hot with Calls? Recruiting Family Practices for a Health Care Research Project. Bleidorn J, Voigt I, Wrede J, Dierks ML, Junius-Walker U, ZFA 2012 88 61 68
51. Increasing response rates to postal questionnaires: systematic review. Edwards P, Roberts I, Clarke M, DiGuiseppi C, Pratap S, Wentz R, Kwan I, BMJ 2002 324 1183 10.1136/bmj.324.7347.1183 12016181
52. Methodologies for improving response rates in surveys of physicians: a systematic review. VanGeest JB, Johnson TP, Welch VL, Eval Health Prof 2007 30 303 321 10.1177/0163278707307899 17986667
53. Physician response to surveys. A review of the literature. Kellerman SE, Herold J, Am J Prev Med 2001 20 61 67 11331134
54. Mayring P, Qualitative Inhaltsanalyse. Grundlagen und Techniken Beltz-UTB: Weinheim 2003
55. Primary care research-trade-off between representativeness and response rate of GP teachers for undergraduates. Lippmann S, Frese T, Herrmann K, Scheller K, Sandholzer H, Swiss Med Wkly 2012 142 13537 22430810
56. How representative of primary care are research active practices? Cross-sectional survey. McManus RJ, Ryan R, Jones M, Wilson S, Hobbs FR, Fam Pract 2008 25 56 62 10.1093/fampra/cmn074 18048650
57. A comparison of research general practices and their patients with other practices-a cross-sectional survey in Trent. Hammersley V, Hippisley-Cox J, Wilson A, Pringle M, Br J Gen Pract 2002 52 463 468 12051210